<?xml version="1.0" encoding="UTF-8"?>
<ref id="j_jtim-2019-0028_ref_050">
 <label>50</label>
 <element-citation publication-type="journal" publication-format="print">
  <name>
   <surname>Souayah</surname>
   <given-names>N</given-names>
  </name>
  <name>
   <surname>Yacoub</surname>
   <given-names>HA</given-names>
  </name>
  <name>
   <surname>Khan</surname>
   <given-names>HM</given-names>
  </name>
  <name>
   <surname>Farhad</surname>
   <given-names>K</given-names>
  </name>
  <name>
   <surname>Mehyar</surname>
   <given-names>LS</given-names>
  </name>
  <name>
   <surname>Maybodi</surname>
   <given-names>L</given-names>
  </name>
  <etal/>
  <article-title>Guillain-Barre syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990â€“2009)</article-title>
  <source>J Clin Neuromuscul Dis</source>
  <year>2012</year>
  <volume>14</volume>
  <fpage>66</fpage>
  <lpage>71</lpage>
  <pub-id pub-id-type="pmid">23172385</pub-id>
 </element-citation>
</ref>
